Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C129822
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/02/109
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
||
|
FDA ORPHAN DRUG |
101396
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8230
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
PRIMARY | Merck Index | ||
|
C1784
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
PRIMARY | |||
|
MM-87
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107917
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
PRIMARY | |||
|
DB04964
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
PRIMARY | |||
|
8183
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
PRIMARY | |||
|
Oregovomab
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
PRIMARY | |||
|
HX101E7L6S
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
PRIMARY | |||
|
213327-37-8
Created by
admin on Sat Dec 16 01:54:11 GMT 2023 , Edited by admin on Sat Dec 16 01:54:11 GMT 2023
|
PRIMARY |
ACTIVE MOIETY